Vis enkel innførsel

dc.contributor.authorPasternak, Björn
dc.contributor.authorWintzell, Viktor
dc.contributor.authorMellbye, Mads
dc.contributor.authorEliasson, Björn
dc.contributor.authorSvensson, Ann-Marie
dc.contributor.authorFranzén, Stefan
dc.contributor.authorGudbjörnsdóttir, Soffia
dc.contributor.authorHveem, Kristian
dc.contributor.authorJonasson, Christian
dc.contributor.authorSvanström, Henrik
dc.contributor.authorUeda, Peter
dc.date.accessioned2023-05-08T10:31:45Z
dc.date.available2023-05-08T10:31:45Z
dc.date.created2020-06-09T14:51:47Z
dc.date.issued2020
dc.identifier.citationBMJ (Clinical Research Edition). 2020, 369 .
dc.identifier.issn0959-8138
dc.identifier.urihttps://hdl.handle.net/11250/3066913
dc.language.isoeng
dc.titleUse of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber9
dc.source.volume369
dc.source.journalBMJ (Clinical Research Edition)
dc.identifier.doi10.1136/bmj.m1186
dc.identifier.cristin1814595
dc.relation.projectStiftelsen Kristian Gerhard Jebsen: SKGJ-MED-015
dc.relation.projectNorges forskningsråd: 248817
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel